| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Aug―29 |
Leveraging the potential of bacterial lateral gene transfer in boosting the efficacy of an edible probiotic prototype yogurt vaccine for COVID-19 |
Madhuri Vissapragada, Santhinissi Addala, Madhumita Aggunna, Manikanta Sodasani, Abhinav V.K.S. Grandhi, Ravikiran S. Yedidi |
| 2 |
[GO] |
2024―Aug―23 |
A SARS-CoV-2 peptide antigen purified from bacteria and displayed in a high-density repetitive manner on a virus-like particle could generate anti-SARS-CoV-2 neutralizing antibodies unlike free peptide |
Feroza Begum, Shreyashi Chandra, Md Hasan Mallik, Jhilik Dey, Prem Prakash Tripathi, Upasana Ray |
| 3 |
[GO] |
2024―Jul―29 |
Structural basis of main proteases of MERS-CoV bound to antineoplastic drug carmofur |
Li Guo, Pei Zeng, Xuelan Zhou, Wenwen Li, Jin Zhang, Jian Li |
| 4 |
[GO] |
2024―Jun―06 |
Structural basis of rosmarinic acid inhibitory mechanism on SARS-CoV-2 main protease |
Qianhui Li, Xuelan Zhou, Weiwei Wang, Qin Xu, Qisheng Wang, Jian Li |
| 5 |
[GO] |
2024―May―19 |
Signal peptide replacement of Ag43 enables an efficient bacterial cell surface display of Receptor-Binding Domain of Coronavirus |
Xuyan Zhang, Youcai Qin, Xiaochen Han, Qingrong Li, Zhe Wang, Xingyuan Wang, Leyi Zhao, Hanqing Zhang, Kun Cai, Yindi Chu, Cuijuan Gao, Enguo Fan |
| 6 |
[GO] |
2024―May―14 |
Mutations in the SARS-CoV-2 Spike proteins affected the ACE2-binding affinity during the development of Omicron pandemic variants. |
Kouichi Tachibana, Yoshihiko Nakamura, Thi Ly Do, Takanori Kihara, Hiroshi Kawada, Norio Yamamoto, Kiyoshi Ando |
| 7 |
[GO] |
2024―May―08 |
A Cell Based Assay Using Virus-like Particles to Screen AM Type Mimics for SARS-CoV-2 Neutralisation |
Neeraj Kailash Gaur, Shreegauri Urankar, Durba Sengupta, V. Ramana Chepuri, Ravindra D. Makde, Kiran Kulkarni |
| 8 |
[GO] |
2024―Apr―23 |
Collection and transportation of SARS-CoV-2 and influenza A virus diagnostic samples: Optimizing the usage of guanidine-based chaotropic salts for enhanced biosafety and viral genome preservation |
James G. Komu, Dulamjav Jamsransuren, Sachiko Matsuda, Haruko Ogawa, Yohei Takeda |
| 9 |
[GO] |
2024―Apr―16 |
Computational investigation of the inhibitory interaction of IRF3 and SARS-CoV-2 accessory protein ORF3b |
Ganggang Bai, Xincheng Zeng, Linghao Zhang, Yanjing Wang, Buyong Ma |
| 10 |
[GO] |
2024―Apr―16 |
Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells |
Magdalena Kulma, Aleksandra Šakanović, Apolonija Bedina-Zavec, Simon Caserman, Neža Omersa, Gašper Šolinc, Sara Orehek, Iva Hafner-Bratkovič, Urška Kuhar, Brigita Slavec, Uroš Krapež, Matjaž Ocepek, Toshihide Kobayashi, Katarzyna Kwiatkowska, Roman Jerala, Marjetka Podobnik, Gregor Anderluh |
| 11 |
[GO] |
2024―Mar―25 |
Agonists or positive allosteric modulators of α7 nicotinic acetylcholine receptor prevent interaction of SARS-Cov-2 receptor-binding domain with astrocytoma cells |
Olena Kalashnyk, Olena Lykhmus, Raymond Sullivan, Serhiy Komisarenko, Maryna Skok |
| 12 |
[GO] |
2024―Mar―23 |
Polylevodopa nanoplatform for lateral flow immunochromatography assay of SARS-CoV-2 and influenza A virus |
Kangsong He, Yabing Ye, Shang Liu, Pengcheng Yuan, Wenjing Sun, Jianbin Tang |
| 13 |
[GO] |
2024―Mar―11 |
Influence of storage solution, temperature, assay time and concentration on RT-qPCR nucleic acid detection for SARS-CoV-2 detection of SARS-CoV-2 by the RT-qPCR |
Lingxuan Su, Yihan Lou, Jiaxuan Li, Haiyan Mao, Jianhua Li, Yi Sun, Biaofeng Zhou, Guangshang Wu, Chen Huang, Yanjun Zhang, Keda Chen |
| 14 |
[GO] |
2023―Dec―16 |
Rapid and high throughput assessment of cellular immunity against SARS-CoV-2 based on the ex vivo activation of genes in leukocyte assay with whole blood |
Taro Saito, Arnaud Couzinet, Taku Murakami, Manami Shimomura, Toshihiro Suzuki, Yuki Katayama, Tetsuya Nakatsura |
| 15 |
[GO] |
2023―Dec―03 |
Crystal structure of SARS-CoV-2 main protease (Mpro) mutants in complex with the non-covalent inhibitor CCF0058981 |
Haihai Jiang, Xiaofang Zou, Xuelan Zhou, Jin Zhang, Jian Li |
| 16 |
[GO] |
2023―Oct―14 |
Cytokines as drivers: Unraveling the mechanisms of epithelial-mesenchymal transition in COVID-19 lung fibrosis |
Lanlan Zhang, Xin Zhang, Xiaoqian Deng, Pengbo Wang, Yan Mo, Yuansheng Zhang, Xia Tong |
| 17 |
[GO] |
2023―Aug―31 |
The basis of complications in the context of SARS-CoV-2 infection: Pathological activation of ADAM17 |
Shenghai Jiang, Hao Yang, Zhongming Sun, Yi Zhang, Yan Li, Jida Li |
| 18 |
[GO] |
2023―Jun―20 |
High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection |
Mizuki Fujisawa, Yu Adachi, Taishi Onodera, Nozomi Shiwa, Naoko Iwata-Yoshikawa, Noriyo Nagata, Tadaki Suzuki, Shinji Takeoka, Yoshimasa Takahashi |
| 19 |
[GO] |
2023―May―18 |
Unwinding mechanism of SARS-CoV helicase (nsp13) in the presence of Ca2+, elucidated by biochemical and single-molecular studies |
Jeongmin Yu, Hyeryeon Im, Gwangrog Lee |
| 20 |
[GO] |
2023―May―02 |
SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate |
Christopher A. Beaudoin, Emmanouela Petsolari, Samir W. Hamaia, Sharif Hala, Fadwa S. Alofi, Arun P. Pandurangan, Tom L. Blundell, Sundeep Chaitanya Vedithi, Christopher L.-H. Huang, Antony P. Jackson |
| 21 |
[GO] |
2023―Apr―18 |
Plasmacytoid dendritic cells stimulated with Lactococcus lactis strain Plasma produce soluble factors to suppress SARS-CoV-2 replication |
Hiroshi Ishii, Kenta Jounai, Ryohei Tsuji, Konomi Ohshio, Daiki Kaneda, Midori Okazaki, Shigeyoshi Harada, Daisuke Fujiwara, Tetsuro Matano |
| 22 |
[GO] |
2023―Apr―05 |
Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2 |
Xiaoyu Chu, Xinyu Ding, Yixuan Yang, Yuchi Lu, Tinghan Li, Yan Gao, Le Zheng, Hang Xiao, Tingting Yang, Hao Cheng, Haibin Huang, Yang Liu, Yang Lou, Chao Wu, Yuxin Chen, Haitao Yang, Xiaoyun Ji, Hangtian Guo |
| 23 |
[GO] |
2023―Mar―23 |
Platelet αIIbβ3 integrin binds to SARS-CoV-2 spike protein of alpha strain but not wild type and omicron strains |
Koyu Ito, Kota Goto, Ryutaro Shirakawa, Hisanori Horiuchi, Kouetsu Ogasawara |
| 24 |
[GO] |
2023―Jan―19 |
Evaluation of a biotin-based surrogate virus neutralization test for detecting postvaccination antibodies against SARS-CoV-2 variants in sera |
Min-Ju Ahn, Jung-Ah Kang, Su Min Hong, Kyu-Sun Lee, Dong Ho Kim, Daesub Song, Dae Gwin Jeong |
| 25 |
[GO] |
2023―Jan―14 |
Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally |
Sho Kawashima, Yuki Matsui, Takumi Adachi, Yuji Morikawa, Kae Inoue, Shiori Takebayashi, Haruaki Nobori, Masatomo Rokushima, Yuki Tachibana, Teruhisa Kato |
| 26 |
[GO] |
2022―Dec―05 |
Spike protein receptor-binding domains from SARS-CoV-2 variants of interest bind human ACE2 more tightly than the prototype spike protein |
Jermilia Charles, Nathan McCann, Victoria A. Ploplis, Francis J. Castellino |
| 27 |
[GO] |
2022―Sep―25 |
SARS-CoV-2-induced hypomethylation of the ferritin heavy chain (FTH1) gene underlies serum hyperferritinemia in severe COVID-19 patients |
Jibran Sualeh Muhammad, Gehad ElGhazali, Jasmin Shafarin, Mohammad G. Mohammad, Ameera Abu-Qiyas, Mawieh Hamad |
| 28 |
[GO] |
2022―Sep―07 |
Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes |
Aditya K. Padhi, Timir Tripathi |
| 29 |
[GO] |
2022―Aug―14 |
Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10 |
Huilin Zhao, Jin Liu, Lei He, Lichuan Zhang, Rilei Yu, Congmin Kang |
| 30 |
[GO] |
2022―Aug―04 |
SARS-CoV-2 spike S1 subunit protein-mediated increase of beta-secretase 1 (BACE1) impairs human brain vessel cells |
Ji-Young Choi, Jung Hyun Park, Chulman Jo, Kyung-Chang Kim, Young Ho Koh |
| 31 |
[GO] |
2022―Aug―02 |
ATP enhances the error-prone ribonucleotide incorporation by the SARS-CoV-2 RNA polymerase |
Yasin Pourfarjam, Zhijun Ma, In-Kwon Kim |
| 32 |
[GO] |
2022―Jul―08 |
Immunization with 674-685 fragment of SARS-Cov-2 spike protein induces neuroinflammation and impairs episodic memory of mice |
Olena Lykhmus, Olena Kalashnyk, Lyudmyla Koval, Olga Krynina, Serhiy Komisarenko, Maryna Skok |
| 33 |
[GO] |
2022―Jun―23 |
SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors |
Pushpendra Mani Mishra, Farhan Anjum, Vladimir N. Uversky, Chayan Kanti Nandi |
| 34 |
[GO] |
2022―Jun―21 |
Diabetic Covid-19 severity: Impaired glucose tolerance and pathologic bone loss |
Jyotirmaya Behera, Jessica Ison, Michael J. Voor, Suresh C. Tyagi, Neetu Tyagi |
| 35 |
[GO] |
2022―May―25 |
Corrigendum to “Biochemical characterization of SARS-CoV-2 nucleocapsid protein” |
Weihong Zeng, Guangfeng Liu, Huan Ma, Dan Zhao, Yunru Yang, Muziying Liu, Ahmed Mohammed, Changcheng Zhao, Yun Yang, Jiajia Xie, Chengchao Ding, Xiaoling Ma, Jianping Weng, Yong Gao, Hongliang He, Tengchuan Jin |
| 36 |
[GO] |
2022―May―13 |
Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease |
Wei Wei, Ni Kong, Ming-Zhen Liu, Ting Han, Jun-Feng Xu, Chong Liu |
| 37 |
[GO] |
2022―May―02 |
A high-affinity aptamer with base-appended base-modified DNA bound to isolated authentic SARS-CoV-2 strains wild-type and B.1.617.2 (delta variant) |
Hirotaka Minagawa, Hirofumi Sawa, Tomoko Fujita, Shintaro Kato, Asumi Inaguma, Miwako Hirose, Yasuko Orba, Michihito Sasaki, Koshiro Tabata, Naoki Nomura, Masashi Shingai, Yasuhiko Suzuki, Katsunori Horii |
| 38 |
[GO] |
2022―Apr―22 |
Crystal structure of SARS-CoV 3C-like protease with baicalein |
Jingwen Feng, Dongyang Li, Jin Zhang, Xiushan Yin, Jian Li |
| 39 |
[GO] |
2022―Apr―20 |
Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral 3CLpro enzymes |
Kazuhiro Sugamoto, Yuri L. Tanaka, Akatsuki Saito, Yoh Goto, Takayuki Nakayama, Tamaki Okabayashi, Hisato Kunitake, Kazuhiro Morishita |
| 40 |
[GO] |
2022―Mar―23 |
High-resolution melting analysis after nested PCR for the detection of SARS-CoV-2 spike protein G339D and D796Y variations |
Hiroshi Miyoshi, Ryu Ichinohe, Takuro Koshikawa |
| 41 |
[GO] |
2022―Mar―18 |
Structural insights revealed by crystal structure of B38-CAP, an isoenzyme of carboxypeptidase ACE2, the receptor of SARS-CoV-2 |
Peiyuan Liu, Yanfeng Zhang, Zibin Li, Jianwen Huang, Tao Wang, Cheng Chen |
| 42 |
[GO] |
2022―Mar―16 |
Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19 |
Davoud Ghazanfari, Maria Cecilia Courreges, Lydia Belinski, Stephen C. Bergmeier, Kelly D. McCall, Douglas J. Goetz |
| 43 |
[GO] |
2022―Mar―14 |
Harnessing coronavirus spike proteins' binding affinity to ACE2 receptor through A novel Baculovirus surface display system |
Lin Wang, Lixia Zhao, Yu Li, Peixiang Ma, Roger D. Kornberg, Yan Nie |
| 44 |
[GO] |
2022―Mar―10 |
Discovery of 4′-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor |
Qianqian Wu, Shiqiang Yan, Yujie Wang, Maotian Li, Yibei Xiao, Yingxia Li |
| 45 |
[GO] |
2022―Feb―23 |
The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity |
Kun Yue, Bin Yao, Yingchao Shi, Yang Yang, Zhaohui Qian, Yali Ci, Lei Shi |
| 46 |
[GO] |
2022―Jan―29 |
The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione |
Mana Murae, Yoshimi Shimizu, Yuichiro Yamamoto, Asuka Kobayashi, Masumi Houri, Tetsuya Inoue, Takuya Irie, Ryutaro Gemba, Yosuke Kondo, Yoshio Nakano, Satoru Miyazaki, Daisuke Yamada, Akiyoshi Saitoh, Isao Ishii, Taishi Onodera, Yoshimasa Takahashi, Takaji Wakita, Masayoshi Fukasawa, Kohji Noguchi |
| 47 |
[GO] |
2022―Jan―15 |
How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17 |
Eamonn F. Healy |
| 48 |
[GO] |
2021―Dec―30 |
Merbromin is a mixed-type inhibitor of 3-chyomotrypsin like protease of SARS-CoV-2 |
Junjie Chen, Yaya Zhang, Dequan Zeng, Bingchang Zhang, Xiaohong Ye, Zhiping Zeng, Xiao-kun Zhang, Zhanxiang Wang, Hu Zhou |
| 49 |
[GO] |
2021―Dec―24 |
Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor |
Cecylia S. Lupala, Yongjin Ye, Hong Chen, Xiao-Dong Su, Haiguang Liu |
| 50 |
[GO] |
2021―Nov―22 |
Emerging mutation patterns in SARS-CoV-2 variants |
David A. Ostrov, Glenn W. Knox |
| 51 |
[GO] |
2021―Nov―20 |
NSP9 of SARS-CoV-2 attenuates nuclear transport by hampering nucleoporin 62 dynamics and functions in host cells |
Kei Makiyama, Masaharu Hazawa, Akiko Kobayashi, Keesiang Lim, Dominic Chih-Cheng Voon, Richard Wong |
| 52 |
[GO] |
2021―Oct―21 |
Linking COVID-19 and Parkinson's disease: Targeting the role of Vitamin-D |
Tapan Behl, Sachin Kumar, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Sridevi Chirgurupati, Maha Aldubayan, Ahmad Alhowail, Saurabh Bhatia, Simona Bungau |
| 53 |
[GO] |
2021―Sep―23 |
SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells |
Luping Zheng, Yingxin Ma, Minghai Chen, Guoqiang Wu, Chuang Yan, Xian-En Zhang |
| 54 |
[GO] |
2021―Sep―15 |
SARS-CoV-2 triggers DNA damage response in Vero E6 cells |
Joshua Victor, Jamie Deutsch, Annalis Whitaker, Erica N. Lamkin, Anthony March, Pei Zhou, Jason W. Botten, Nimrat Chatterjee |
| 55 |
[GO] |
2021―Sep―13 |
The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2 |
Dong-Kyun Ryu, Bobin Kang, Hanmi Noh, Sun-Je Woo, Min-Ho Lee, Patricia M. Nuijten, Jong-In Kim, Ji-Min Seo, Cheolmin Kim, Minsoo Kim, Eunji Yang, Gippeum Lim, Seong-Gyu Kim, Su-Kyeong Eo, Jung-ah Choi, Manki Song, Sang-Seok Oh, Hyo-Young Chung, Aloys SL. Tijsma, Carel A. van Baalen, Ki-Sung Kwon, Soo-Young Lee |
| 56 |
[GO] |
2021―Sep―08 |
Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells |
Michihito Sasaki, Mai Kishimoto, Yukari Itakura, Koshiro Tabata, Kittiya Intaruck, Kentaro Uemura, Shinsuke Toba, Takao Sanaki, Akihiko Sato, William W. Hall, Yasuko Orba, Hirofumi Sawa |
| 57 |
[GO] |
2021―Aug―23 |
Strong alkaline electrolyzed water efficiently inactivates SARS-CoV-2, other viruses, and Gram-negative bacteria |
Youichi Suzuki, Takayuki Hishiki, Akino Emi, Shoichi Sakaguchi, Ronko Itamura, Rain Yamamoto, Tamio Matsuzawa, Kunitada Shimotohno, Masashi Mizokami, Takashi Nakano, Naoki Yamamoto |
| 58 |
[GO] |
2021―Aug―15 |
A model for COVID-19-induced dysregulation of ACE2 shedding by ADAM17 |
Eamonn F. Healy, Marko Lilic |
| 59 |
[GO] |
2021―Aug―15 |
Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion |
Prabin Baral, Nisha Bhattarai, Md Lokman Hossen, Vitalii Stebliankin, Bernard S. Gerstman, Giri Narasimhan, Prem P. Chapagain |
| 60 |
[GO] |
2021―Jul―20 |
A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding |
Yingyi Long, Shuyi Song, Feiyang Luo, Xiaojian Han, Chao Hu, Yingming Wang, Shenglong Li, Wang Wang, Huajun Zhang, Bo Zhang, Tingting Li, Aishun Jin |
| 61 |
[GO] |
2021―Jul―16 |
Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight |
Feroza Begum, Amit Kumar Srivastava, Upasana Ray |
| 62 |
[GO] |
2021―Jul―13 |
Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro |
Mami Oba, Wen Rongduo, Akatsuki Saito, Tamaki Okabayashi, Tomoko Yokota, Junko Yasuoka, Yoko Sato, Koji Nishifuji, Hitoshi Wake, Yutaka Nibu, Tetsuya Mizutani |
| 63 |
[GO] |
2021―Jul―02 |
Analysis of SARS-CoV-2 nucleocapsid phosphoprotein N variations in the binding site to human 14-3-3 proteins |
Samanta Del Veliz, Lautaro Rivera, Diego M. Bustos, Marina Uhart |
| 64 |
[GO] |
2021―Jun―10 |
Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method |
Kevin Maafu Juma, Teisuke Takita, Kenji Ito, Masaya Yamagata, Shihomi Akagi, Emi Arikawa, Kenji Kojima, Manish Biyani, Shinsuke Fujiwara, Yukiko Nakura, Itaru Yanagihara, Kiyoshi Yasukawa |
| 65 |
[GO] |
2021―Jun―07 |
Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant |
Dong-Kyun Ryu, Rina Song, Minsoo Kim, Young-Il Kim, Cheolmin Kim, Jong-In Kim, Ki-Sung Kwon, Aloys SL. Tijsma, Patricia M. Nuijten, Carel A. van Baalen, Tandile Hermanus, Prudence Kgagudi, Thandeka Gwete-Moyo, Penny L. Moore, Young Ki Choi, Soo-Young Lee |
| 66 |
[GO] |
2021―Jun―05 |
Analysis of the molecular mechanism of SARS-CoV-2 antibodies |
Dongfu Jin, Jing Wei, Jian Sun |
| 67 |
[GO] |
2021―May―29 |
Quantitative circular flow immunoassays with trained object recognition to detect antibodies to SARS-CoV-2 membrane glycoprotein |
Ryan Yuki Huang, Deron Raymond Herr |
| 68 |
[GO] |
2021―May―26 |
Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant |
Shinya Ohki, Tomohiro Imamura, Yasuki Higashimura, Kenji Matsumoto, Masashi Mori |
| 69 |
[GO] |
2021―May―21 |
Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective |
Ibrahim M. Ibrahim, Abdo A. Elfiky, Alaa M. Elgohary |
| 70 |
[GO] |
2021―May―11 |
SARS-Cov-2 spike protein fragment 674-685 protects mitochondria from releasing cytochrome c in response to apoptogenic influence |
Olena Kalashnyk, Olena Lykhmus, Mykhailo Izmailov, Lyudmyla Koval, Serhiy Komisarenko, Maryna Skok |
| 71 |
[GO] |
2021―Apr―21 |
Production in Escherichia coli of recombinant COVID-19 spike protein fragments fused to CRM197 |
Bellone Maria Laura, Puglisi Andrea, Dal Piaz Fabrizio, Hochkoeppler Alejandro |
| 72 |
[GO] |
2021―Apr―08 |
In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5 |
Dai Hatakeyama, Takeshi Masuda, Ryosuke Miki, Sumio Ohtsuki, Takashi Kuzuhara |
| 73 |
[GO] |
2021―Mar―26 |
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model |
Koen Vandyck, Rana Abdelnabi, Kusum Gupta, Dirk Jochmans, Andreas Jekle, Jerome Deval, Dinah Misner, Dorothée Bardiot, Caroline S. Foo, Cheng Liu, Suping Ren, Leonid Beigelman, Lawrence M. Blatt, Sandro Boland, Laura Vangeel, Steven Dejonghe, Patrick Chaltin, Arnaud Marchand, Vladimir Serebryany, Antitsa Stoycheva, Sushmita Chanda, Julian A. Symons, Pierre Raboisson, Johan Neyts |
| 74 |
[GO] |
2021―Mar―26 |
Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation |
Aditya K. Padhi, Timir Tripathi |
| 75 |
[GO] |
2021―Mar―24 |
SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration |
Danish Idress, Vijay Kumar |
| 76 |
[GO] |
2021―Mar―19 |
A tissue- and gender-specific regulation of the SARS-CoV-2 receptor ACE2 by p53 in pigs |
Yue Zhang, Guanglin Niu, Tatiana Flisikowska, Angelika Schnieke, Krzysztof Flisikowski |
| 77 |
[GO] |
2021―Mar―15 |
A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2 |
Robert L. Kruse, Yuting Huang, Heather Smetana, Eric A. Gehrie, Tim K. Amukele, Aaron A.R. Tobian, Heba H. Mostafa, Zack Z. Wang |
| 78 |
[GO] |
2021―Feb―26 |
SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring |
Filipe Pereira |
| 79 |
[GO] |
2021―Feb―15 |
Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity |
Sandipan Chakraborty |
| 80 |
[GO] |
2021―Feb―13 |
Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand |
Kannikar Intawong, Debra Olson, Suwat Chariyalertsak |
| 81 |
[GO] |
2021―Feb―10 |
EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro |
Minsu Jang, Rackhyun Park, Yea-In Park, Yeo-Eun Cha, Ayane Yamamoto, Jin I. Lee, Junsoo Park |
| 82 |
[GO] |
2021―Feb―04 |
H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine |
Eduardo Alfredo Adami, Stefanni Liliane Chavez Rico, Milena Apetito Akamatsu, Cosue Miyaki, Isaías Raw, Dourival de Oliveira, Priscila Comone, Ricardo das Neves Oliveira, Maria Leonor Sarno de Oliveira, Patrícia Antônia Estima Abreu, Carolina Yumi Takano, Maurício Meros, Alessandra Soares-Schanoski, Paulo Lee Ho |
| 83 |
[GO] |
2021―Jan―29 |
5-amino levulinic acid inhibits SARS-CoV-2 infection |
Yasuteru Sakurai, Mya Myat Ngwe Tun, Yohei Kurosaki, Takaya Sakura, Daniel Ken Inaoka, Kiyotaka Fujine, Kiyoshi Kita, Kouichi Morita, Jiro Yasuda |
| 84 |
[GO] |
2021―Jan―22 |
The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients |
Veronique A.J. Smits, Esperanza Hernández-Carralero, María Cristina Paz-Cabrera, Elisa Cabrera, Yeray Hernández-Reyes, Juan Ramón Hernández-Fernaud, David A. Gillespie, Eduardo Salido, Miriam Hernández-Porto, Raimundo Freire |
| 85 |
[GO] |
2021―Jan―15 |
ATP biphasically modulates LLPS of SARS-CoV-2 nucleocapsid protein and specifically binds its RNA-binding domain |
Mei Dang, Yifan Li, Jianxing Song |
| 86 |
[GO] |
2021―Jan―15 |
RNA sequence and ligand binding alter conformational profile of SARS-CoV-2 stem loop II motif |
Ali H. Aldhumani, Md Ismail Hossain, Emily A. Fairchild, Hannah Boesger, Emily C. Marino, Mason Myers, Jennifer V. Hines |
| 87 |
[GO] |
2021―Jan―10 |
Nonlinear adaptive control of COVID-19 with media campaigns and treatment |
Boqiang Cao, Ting Kang |
| 88 |
[GO] |
2021―Jan―08 |
The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy |
Yasir Mohamud, Yuan Chao Xue, Huitao Liu, Chen Seng Ng, Amirhossein Bahreyni, Eric Jan, Honglin Luo |
| 89 |
[GO] |
2021―Jan―06 |
The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease |
Wei-Chung Chiou, Jui-Chieh Chen, Jinn-Moon Yang, Lih-Hwa Hwang, Yi-Shuan Lyu, Hsin-Yi Yang, Cheng Huang |
| 90 |
[GO] |
2021―Jan―01 |
Pathogenesis of COVID-19 and the quality control of nucleic acid detection |
Xiao-Dong Mao, Taiping Li, Zhirong Xu, Kangsheng Liu |
| 91 |
[GO] |
2020―Dec―26 |
In silico study of the potential interactions of 4′-acetamidechalcones with protein targets in SARS-CoV-2 |
Francisco Wagner Q. Almeida-Neto, Maria Geysillene Castro Matos, Emanuelle M. Marinho, Márcia M. Marinho, Ramon R.P.P.B. de Menezes, Tiago L. Sampaio, Paulo N. Bandeira, Carla Freire Celedonio Fernandes, Alexandre M.Rodrigues Teixeira, Emmanuel S. Marinho, Pedro de Lima-Neto, Hélcio S. dos Santos |
| 92 |
[GO] |
2020―Dec―24 |
Comprehensive analysis of COVID-19 during pregnancy |
Kathryn M. Moore, Mehul S. Suthar |
| 93 |
[GO] |
2020―Dec―13 |
Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex |
Koki Kato, Dini Kurnia Ikliptikawati, Akiko Kobayashi, Hiroya Kondo, Keesiang Lim, Masaharu Hazawa, Richard W. Wong |
| 94 |
[GO] |
2020―Dec―09 |
Range of reproduction number estimates for COVID-19 spread |
Damiano Pasetto, Joseph C. Lemaitre, Enrico Bertuzzo, Marino Gatto, Andrea Rinaldo |
| 95 |
[GO] |
2020―Dec―05 |
A perspective on early detection systems models for COVID-19 spreading |
Chiara Vianello, Fernanda Strozzi, Paolo Mocellin, Elisa Cimetta, Bruno Fabiano, Flavio Manenti, Rossella Pozzi, Giuseppe Maschio |
| 96 |
[GO] |
2020―Dec―03 |
Identification of antiviral antihistamines for COVID-19 repurposing |
Leah R. Reznikov, Michael H. Norris, Rohit Vashisht, Andrew P. Bluhm, Danmeng Li, Yan-Shin J. Liao, Ashley Brown, Atul J. Butte, David A. Ostrov |
| 97 |
[GO] |
2020―Nov―28 |
Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors |
Daoqun Li, Junwen Luan, Leiliang Zhang |
| 98 |
[GO] |
2020―Nov―28 |
The biogenesis of SARS-CoV-2 spike glycoprotein: Multiple targets for host-directed antiviral therapy |
Silvia Santopolo, Anna Riccio, M. Gabriella Santoro |
| 99 |
[GO] |
2020―Nov―28 |
Structural stability of SARS-CoV-2 virus like particles degrades with temperature |
A. Sharma, B. Preece, H. Swann, X. Fan, R.J. McKenney, K.M. Ori-McKenney, S. Saffarian, M.D. Vershinin |
| 100 |
[GO] |
2020―Nov―28 |
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature |
Erica Bacca, Margherita Digaetano, Marianna Meschiari, Erica Franceschini, Marianna Menozzi, Gianluca Cuomo, Cristina Mussini |
| 101 |
[GO] |
2020―Nov―28 |
Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity |
Sandipan Chakraborty |
| 102 |
[GO] |
2020―Nov―21 |
The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2 |
Zhenming Jin, Haofeng Wang, Yinkai Duan, Haitao Yang |
| 103 |
[GO] |
2020―Nov―20 |
Remdesivir: From Ebola to COVID-19 |
M. Gabriella Santoro, Ernesto Carafoli |
| 104 |
[GO] |
2020―Nov―20 |
Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches |
Koichi Watashi |
| 105 |
[GO] |
2020―Nov―20 |
Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics |
Martin A. Walsh, Jonathan M. Grimes, David I. Stuart |
| 106 |
[GO] |
2020―Nov―20 |
Dual ELISA using SARS-CoV-2 nucleocapsid protein produced in E. coli and CHO cells reveals epitope masking by N-glycosylation |
Airi Rump, Robert Risti, Mai-Ly Kristal, Jekaterina Reut, Vitali Syritski, Aivar Lookene, Sirje Ruutel Boudinot |
| 107 |
[GO] |
2020―Nov―17 |
Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2 |
Marcelo A. Lima, Mark Skidmore, Farhat Khanim, Alan Richardson |
| 108 |
[GO] |
2020―Nov―17 |
Vaccine-induced protection in aging adults and pandemic response |
Theodore Schenkelberg |
| 109 |
[GO] |
2020―Nov―13 |
A nidovirus perspective on SARS-CoV-2 |
Anastasia A. Gulyaeva, Alexander E. Gorbalenya |
| 110 |
[GO] |
2020―Nov―13 |
Functional importance of the D614G mutation in the SARS-CoV-2 spike protein |
Cody B. Jackson, Lizhou Zhang, Michael Farzan, Hyeryun Choe |
| 111 |
[GO] |
2020―Nov―11 |
Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand |
Kannikar Intawong, Debra Olson, Suwat Chariyalertsak |
| 112 |
[GO] |
2020―Nov―07 |
T-cell dysregulation in COVID-19 |
Bahire Kalfaoglu, José Almeida-Santos, Chanidapa Adele Tye, Yorifumi Satou, Masahiro Ono |
| 113 |
[GO] |
2020―Nov―07 |
Proactive and blended approach for COVID-19 control in Taiwan |
Hao-Yuan Cheng, Angela Song-En Huang |
| 114 |
[GO] |
2020―Nov―07 |
Biochemical and Biophysical Research Communications History of the COVID-19 pandemic: Origin, explosion, worldwide spreading |
Sara Platto, Yanqing Wang, Jinfeng Zhou, Ernesto Carafoli |
| 115 |
[GO] |
2020―Nov―07 |
Evolution patterns of SARS-CoV-2: Snapshot on its genome variants |
Marta Giovanetti, Francesca Benedetti, Giovanni Campisi, Alessandra Ciccozzi, Silvia Fabris, Giancarlo Ceccarelli, Victor Tambone, Arnaldo Caruso, Silvia Angeletti, Davide Zella, Massimo Ciccozzi |
| 116 |
[GO] |
2020―Nov―07 |
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity |
Jorge Carrillo, Nuria Izquierdo-Useros, Carlos Ávila-Nieto, Edwards Pradenas, Bonaventura Clotet, Julià Blanco |
| 117 |
[GO] |
2020―Nov―05 |
Host-directed editing of the SARS-CoV-2 genome |
Tobias Mourier, Mukhtar Sadykov, Michael J. Carr, Gabriel Gonzalez, William W. Hall, Arnab Pain |
| 118 |
[GO] |
2020―Nov―05 |
The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design |
Danielle C. Groves, Sarah L. Rowland-Jones, Adrienn Angyal |
| 119 |
[GO] |
2020―Nov―02 |
Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19 |
Dylan C. Sarver, G. William Wong |
| 120 |
[GO] |
2020―Oct―28 |
Laboratory testing for the diagnosis of COVID-19 |
Christopher Koon Chi Lai, Wilson Lam |
| 121 |
[GO] |
2020―Oct―26 |
Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives |
Cheryl Baxter, Quarraisha Abdool Karim, Salim S. Abdool Karim |
| 122 |
[GO] |
2020―Oct―23 |
T cell immunity to SARS-CoV-2 following natural infection and vaccination |
Anthony T. DiPiazza, Barney S. Graham, Tracy J. Ruckwardt |
| 123 |
[GO] |
2020―Oct―21 |
Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2 |
Luca Zinzula |
| 124 |
[GO] |
2020―Oct―21 |
The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2? |
David A. Jans, Kylie M. Wagstaff |
| 125 |
[GO] |
2020―Oct―16 |
Biodiversity loss and COVID-19 pandemic: The role of bats in the origin and the spreading of the disease |
Sara Platto, Jinfeng Zhou, Yanqing Wang, Huo Wang, Ernesto Carafoli |
| 126 |
[GO] |
2020―Oct―10 |
Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19 |
Jacques Fantini, Henri Chahinian, Nouara Yahi |
| 127 |
[GO] |
2020―Oct―10 |
Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies |
Meng Yuan, Hejun Liu, Nicholas C. Wu, Ian A. Wilson |
| 128 |
[GO] |
2020―Oct―03 |
High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2 |
Luca Zinzula, Jerome Basquin, Stefan Bohn, Florian Beck, Sven Klumpe, Günter Pfeifer, István Nagy, Andreas Bracher, F. Ulrich Hartl, Wolfgang Baumeister |
| 129 |
[GO] |
2020―Sep―30 |
Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection |
Ernesto Carafoli |
| 130 |
[GO] |
2020―Sep―18 |
Machine learning methods accurately predict host specificity of coronaviruses based on spike sequences alone |
Kiril Kuzmin, Ayotomiwa Ezekiel Adeniyi, Arthur Kevin DaSouza, Deuk Lim, Huyen Nguyen, Nuria Ramirez Molina, Lanqiao Xiong, Irene T. Weber, Robert W. Harrison |
| 131 |
[GO] |
2020―Sep―14 |
The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues |
Jialu Qiao, Weiling Li, Jian Bao, Qian Peng, Dongmei Wen, Jianing Wang, Binlian Sun |
| 132 |
[GO] |
2020―Sep―11 |
Potent antiviral effect of silver nanoparticles on SARS-CoV-2 |
Sundararaj S. Jeremiah, Kei Miyakawa, Takeshi Morita, Yutaro Yamaoka, Akihide Ryo |
| 133 |
[GO] |
2020―Sep―04 |
RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19 |
Yi Jiang, Wanchao Yin, H. Eric Xu |
| 134 |
[GO] |
2020―Aug―25 |
Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage |
Tzu-Hau Shi, Yi-Long Huang, Chiao-Che Chen, Wen-Chieh Pi, Yu-Ling Hsu, Lee-Chiang Lo, Wei-Yi Chen, Shu-Ling Fu, Chao-Hsiung Lin |
| 135 |
[GO] |
2020―Aug―15 |
Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3 |
H.Y. Lim Tung, Pierre Limtung |
| 136 |
[GO] |
2020―Jul―21 |
Establishment and validation of a drug-target microarray for SARS-CoV-2 |
Peng Chen, Zehua Zeng, Hongwu Du |
| 137 |
[GO] |
2020―Jul―14 |
Acidic electrolyzed water potently inactivates SARS-CoV-2 depending on the amount of free available chlorine contacting with the virus |
Yohei Takeda, Hiroshi Uchiumi, Sachiko Matsuda, Haruko Ogawa |
| 138 |
[GO] |
2020―Jun―20 |
SARS-CoV-2 E protein is a potential ion channel that can Be inhibited by Gliclazide and Memantine |
Prabhat Pratap Singh Tomar, Isaiah T. Arkin |
| 139 |
[GO] |
2020―Jun―16 |
Proteasome activator PA28γ-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein |
Haiyang Zhang, Jialu Tu, Chulei Cao, Ting Yang, Liangcai Gao |
| 140 |
[GO] |
2020―Jun―09 |
Efficient production of recombinant SARS-CoV-2 spike protein using the baculovirus-silkworm system |
Ryosuke Fujita, Masato Hino, Takeru Ebihara, Takumi Nagasato, Akitsu Masuda, Jae Man Lee, Tsuguru Fujii, Hiroaki Mon, Kohei Kakino, Ryo Nagai, Miyu Tanaka, Yoshino Tonooka, Takato Moriyama, Takahiro Kusakabe |
| 141 |
[GO] |
2020―Jun―08 |
Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents |
Lalu Muhammad Irham, Wan-Hsuan Chou, Marcus J. Calkins, Wirawan Adikusuma, Shie-Liang Hsieh, Wei-Chiao Chang |
| 142 |
[GO] |
2020―May―29 |
Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke |
Choi Ji-Young, Lee Hye-Kyung, Park Jung Hyun, Cho Sun-Jung, Kwon Munjin, Jo Chulman, Koh Young Ho |
| 143 |
[GO] |
2020―May―14 |
Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism |
Houcemeddine Othman, Zied Bouslama, Jean-Tristan Brandenburg, Jorge da Rocha, Yosr Hamdi, Kais Ghedira, Najet Srairi-Abid, Scott Hazelhurst |
| 144 |
[GO] |
2020―May―06 |
Stability of RNA sequences derived from the coronavirus genome in human cells |
Hiroyasu Wakida, Kentaro Kawata, Yuta Yamaji, Emi Hattori, Takaho Tsuchiya, Youichiro Wada, Haruka Ozaki, Nobuyoshi Akimitsu |
| 145 |
[GO] |
2020―Apr―30 |
Biochemical characterization of SARS-CoV-2 nucleocapsid protein |
Weihong Zeng, Guangfeng Liu, Huan Ma, Dan Zhao, Yunru Yang, Muziying Liu, Ahmed Mohammed, Changcheng Zhao, Yun Yang, Jiajia Xie, Chengchao Ding, Xiaoling Ma, Jianping Weng, Yong Gao, Hongliang He, Tengchuan Jin |
| 146 |
[GO] |
2020―Apr―09 |
A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization |
Pietro Bongini, Alfonso Trezza, Monica Bianchini, Ottavia Spiga, Neri Niccolai |
| 147 |
[GO] |
2020―Mar―19 |
Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses |
Furong Qi, Shen Qian, Shuye Zhang, Zheng Zhang |
| 148 |
[GO] |
2020―Mar―19 |
Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection |
Junwen Luan, Yue Lu, Xiaolu Jin, Leiliang Zhang |
| 149 |
[GO] |
2020―Feb―17 |
Structure analysis of the receptor binding of 2019-nCoV |
Yun Chen, Yao Guo, Yihang Pan, Zhizhuang Joe Zhao |
